Approval · Notice of Compliance 15551 · 2014
PREFESTA: Notice of Compliance 15551
Issued April 29, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15551
- Date
- April 29, 2014
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Therapeutic class
- Hormone replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREFESTA | 02247906 | Cancelled Pre Market |
Medicinal ingredients
- ESTRADIOL 1 MG per TAB
- NORGESTIMATE 90 MCG per TAB